US Patent 12006361 Albumin binding domain fusion proteins
Patent 12006361 was granted and assigned to Sonnet Biotherapeutics, Inc. on June, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+29 properties)
Article (+305 characters)
US Patent 12006361 Albumin binding domain fusion proteins
Article
Patent abstract
Compositions that include an albumin binding domain and a fusion partner (e.g., a cytokine or a binding moiety) are provided. Such therapeutics have increased serum half-life and find use in applications where one or more such therapeutics are needed, for example, in oncology applications.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Haomin Huang0
John K. Cini0
Date of Patent
June 11, 2024
0Patent Application Number
173078840
Date Filed
May 4, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12006361 Albumin binding domain fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
